Skip to content

Drug interactions

Bosentan + Pimavanserin

Severity: Moderate

Bosentan and Pimavanserin: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Bosentan is a moderate CYP3A4 inducer and may lower pimavanserin exposure, potentially reducing antipsychotic effect in Parkinson's disease psychosis. Strong inducers are labeled to be avoided, and moderate inducers can have a similar but smaller effect.

What this interaction means in plain words

Bosentan and Pimavanserin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Bosentan belongs to Miscellaneous; Pimavanserin belongs to Central Nervous System.

Evidence level: Moderate

Why it happens

Bosentan induces CYP3A4, increasing pimavanserin metabolism.

What to do

Monitor for loss of psychosis control and consider increasing the pimavanserin dose if efficacy declines.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Bosentan and Pimavanserin, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Bosentan with Pimavanserin?

MediHelp rates the interaction as moderate. Bosentan and Pimavanserin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Bosentan is a moderate CYP3A4 inducer and may lower pimavanserin exposure, potentially reducing antipsychotic effect in Parkinson's disease psychosis. Strong inducers are labeled to be avoided, and moderate inducers can have a similar but smaller effect.

How serious is the interaction between Bosentan and Pimavanserin?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for loss of psychosis control and consider increasing the pimavanserin dose if efficacy declines.

What other medicines interact with Bosentan?

MediHelp also lists interactions of Bosentan with, for example, Cyclosporin, Glibenclamide, Glyburide-metformin. The full list is on the Bosentan page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in